↓ Skip to main content

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent
11 patents

Citations

dimensions_citation
167 Dimensions

Readers on

mendeley
136 Mendeley
Title
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Published in
Cancer Immunology, Immunotherapy, April 2011
DOI 10.1007/s00262-011-1021-7
Pubmed ID
Authors

Hirohito Kobayashi, Yoshimasa Tanaka, Junji Yagi, Nagahiro Minato, Kazunari Tanabe

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Denmark 1 <1%
France 1 <1%
Unknown 133 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 15%
Researcher 17 13%
Student > Master 17 13%
Student > Doctoral Student 12 9%
Student > Bachelor 12 9%
Other 21 15%
Unknown 36 26%
Readers by discipline Count As %
Medicine and Dentistry 29 21%
Immunology and Microbiology 22 16%
Agricultural and Biological Sciences 21 15%
Biochemistry, Genetics and Molecular Biology 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 9 7%
Unknown 41 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#3,380,475
of 23,377,816 outputs
Outputs from Cancer Immunology, Immunotherapy
#230
of 2,925 outputs
Outputs of similar age
#15,940
of 111,515 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 24 outputs
Altmetric has tracked 23,377,816 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,925 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.